Cite
HARVARD Citation
Kuo, B. et al. (2021). Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK‐906), a dopamine D2/D3 receptor antagonist, in patients with gastroparesis. Alimentary pharmacology & therapeutics. 54 (3), pp. 267-280. [Online].